Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Kim
Peter J Neumann

Showing results (31-40 of 436) with videos related to

Pageof 44
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
Budget impact analyses get some respectPeter J Neumann
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Where are we on "risk-sharing" agreements?Peter J Neumann
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 13, 2019
Yes, Improve the US Value Frameworks, But Recognize They Are Already in Prime TimePeter J Neumann
Health Affairs (Project Hope)|January 30, 2007
Challenges ahead for federal technology assessmentPeter J Neumann
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 29, 2008
What ever happened to FDAMA Section 114? A look back after 10 yearsPeter J Neumann
Medical Care|August 2, 2005
The arrival of economic evidence in managed care formulary decisions: the unsolicited request processPeter J Neumann
Health Affairs (Project Hope)|January 8, 2019
Targeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic EfficiencyDavid D Kim, Joshua T Cohen, John B Wong, et al.
Gates Open Research|September 25, 2019
Comparing the cost-per-QALYs gained and cost-per-DALYs averted literaturesPeter J Neumann, Jordan E Anderson, Ari D Panzer, et al.
JAMA Network Open|November 22, 2022
Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and SpendingDavid D Kim, Allan T Daly, Benjamin C Koethe, et al.
Journal of General Internal Medicine|February 23, 2021
An Evidence Review of Low-Value Care Recommendations: Inconsistency and Lack of Economic Evidence ConsideredDavid D Kim, Lauren A Do, Allan T Daly, et al.
Pageof 44

Showing results (31-40 of 436) with videos related to

Sort By:
Pageof 44
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
Budget impact analyses get some respectPeter J Neumann
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Where are we on "risk-sharing" agreements?Peter J Neumann
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 13, 2019
Yes, Improve the US Value Frameworks, But Recognize They Are Already in Prime TimePeter J Neumann
Health Affairs (Project Hope)|January 30, 2007
Challenges ahead for federal technology assessmentPeter J Neumann
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 29, 2008
What ever happened to FDAMA Section 114? A look back after 10 yearsPeter J Neumann
Medical Care|August 2, 2005
The arrival of economic evidence in managed care formulary decisions: the unsolicited request processPeter J Neumann
Health Affairs (Project Hope)|January 8, 2019
Targeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic EfficiencyDavid D Kim, Joshua T Cohen, John B Wong, et al.
Gates Open Research|September 25, 2019
Comparing the cost-per-QALYs gained and cost-per-DALYs averted literaturesPeter J Neumann, Jordan E Anderson, Ari D Panzer, et al.
JAMA Network Open|November 22, 2022
Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and SpendingDavid D Kim, Allan T Daly, Benjamin C Koethe, et al.
Journal of General Internal Medicine|February 23, 2021
An Evidence Review of Low-Value Care Recommendations: Inconsistency and Lack of Economic Evidence ConsideredDavid D Kim, Lauren A Do, Allan T Daly, et al.
Pageof 44